CPM Webinar Series: Creating and Running an Ethical IP Law Firm: A Survival Guide For Patent & Trademark Practitioners - Part 1
October 6, 2022 12:30 PM to 2:00 PM
Introduction and Overview of Legal and Ethical Duties IP Practitioners Owe to Clients, the Public, and the USPTO
This first part of AIPLA’s six-part webinar series lays the foundation for creating and running an ethical IP firm. During this inaugural session, explore who you may be working with, employing, and partnering with when designing and running an IP law firm and how each of these roles and positions can impact your practice and practice areas.
In addition, you will hear about the legal and ethical duties IP practitioners and their law firms owe to their clients, the USPTO (and other tribunals), adverse parties, third parties, and members of the public and how these duties impact your practice and potential for disciplinary action. Practitioner-client relationship formation and termination will also be discussed.
Subsequent parts in this six-part webinar series will build from these overarching principles. Monthly deep dives into specific practice tips will be provided outside of this webinar series through the support of a variety of AIPLA committees – stay tuned for dates, times, and topics.
Presented by: Michael McCabe, McCabe Ali LLC, and Jan Jacobowitz, Legal Ethics Consulting
This program is a FREE, members-only benefit
No CLE
News
-
Supreme Court Issues Unanimous Decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc.
June 4, 2026
On June 4, 2026, the Supreme Court issued a unanimous decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. While the Court reaffirmed existing law on pleading standards, it reversed the Federal Circuit’s decision that had focused on how relevant statements could be understood by medical providers as instructions to infringe. The amicus brief filed by AIPLA on March 27, 2026, advocated for affirmance and cautioned the Court not to change the patent infringement pleading standard or adopt any categorical exemption from inducement for a particular industry. -
AIPLA Submits Comments to the USPTO on 2026 Supplemental GUI Guidance
May 15, 2026
Arlington, VA. May 12, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments to the USPTO on its Supplemental Guidance for Examination of Design Patent Applications Related to Computer-Generated Interfaces and Icons, issued on March 13, 2026. -
AIPLA Comments on the Copyright Office's Proposed Fee Schedule Adjustment
May 8, 2026
Arlington, VA. May 1, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments in response to the U.S. Copyright Office’s Notice of Proposed Rulemaking on adjustments to its fee schedule. -
AIPLA Submits Comments on the Enlarged Board of Appeal’s 11 Preliminary Opinion in G 1/25
May 1, 2026
Arlington, VA. April 17, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments on the Enlarged Board of Appeal’s 11 March 2026 preliminary opinion in G 1/25, addressing whether patent descriptions must be adapted following claim amendments. -
AIPLA Files Amicus Brief in Range of Motion Products, LLC v. Armaid Company Inc.
April 20, 2026
Arlington, VA — April 17, 2026 — The American Intellectual Property Law Association (AIPLA) filed an amicus curiae brief with the U.S. Court of Appeals for the Federal Circuit in Range of Motion Products, LLC v. Armaid Company Inc., No. 23-2427, supporting rehearing and rehearing en banc. AIPLA urges the Court to restore clarity to design patent law by (1) reaffirming that Gorham v. White (1871) provides the sole governing test for infringement and forecloses any separate “plainly dissimilar” threshold, and (2) confirming that claim construction may not be used to exclude any visual portions of the overall claimed design.